Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Edward M Basile Insider Profile
4 Followers
Edward M Basile, Director at TransMedics Group, holds 732.00 shares in TransMedics Group (Ticker: TMDX). Most recently, Edward M Basile Sold $1,193 shares of TransMedics Group on Jun 07, 2024 for an estimated value of 164.73K.
Profitable Transactions
0 out of 4 Profitable Transactions
Average Return
-12.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Edward M Basile's holdings
Insider Roles
Director
Roles that Edward M Basile holds in companies
Most Profitable Insider Trade
The most profitable trade made by Edward M Basile
Edward M Basile's Trading History
List of latest transactions for each holding click on a transaction to see Edward M Basile's performance on stock
You May Also Like
Edward M Basile insider profile FAQ
What is the percentage of profitable transactions made by Edward M Basile?
The percentage of profitable transactions made by Edward M Basile is 0%.
What is the average return per transaction made by Edward M Basile?
The average return per transaction made by Edward M Basile is -12.80%.
What stocks does Edward M Basile hold?
Edward M Basile holds: TMDX stocks.
What was Edward M Basile’s latest transaction?
Edward M Basile latest transaction was an Informative Sell of $164.73K.
What was Edward M Basile's most profitable transaction?
Edward M Basile’s most profitable transaction was an Informative Sell of TMDX stock on February 28, 2023. The return on the trade was -2.40%.
What is Edward M Basile's role in TransMedics Group?
Edward M Basile's role in TransMedics Group is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.